Disability progression is a question of definition - a methodological reappraisal by example of primary progressive multiple sclerosis

被引：0

作者：

Bsteh, Gabriel ^{[1
,2
]}

Marti, Stefanie ^{[3
,4
]}

Hegen, Harald ^{[5
]}

Krajnc, Nik ^{[1
,2
]}

Traxler, Gerhard ^{[6
]}

Hammer, Helly ^{[3
,4
]}

Rommer, Paulus ^{[1
,2
]}

Leutmezer, Fritz ^{[1
,2
]}

Di Pauli, Franziska ^{[5
]}

Chan, Andrew ^{[3
,4
]}

Berger, Thomas ^{[1
,2
]}

Hoepner, Robert ^{[3
,4
]}

机构：

[1] Med Univ Vienna, Dept Neurol, Vienna, Austria

[2] Med Univ Vienna, Comprehens Ctr Clin Neurosci & Mental Hlth, Vienna, Austria

[3] Bern Univ Hosp, Bern, Switzerland

[4] Univ Bern, Dept Neurol, Bern, Switzerland

[5] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria

[6] Kepler Univ Hosp GmbH, Dept Neurol, Med Campus 3, Linz, Austria

来源：

MULTIPLE SCLEROSIS JOURNAL | 2023年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P773/3087

引用

页码：1091 / 1092

页数：2

共 50 条

[1] Disability progression is a question of definition-A methodological reappraisal by example of primary progressive multiple sclerosis
Bsteh, Gabriel
Marti, Stefanie
Krajnc, Nik
Traxler, Gerhard
Salmen, Anke
Hammer, Helly
Leutmezer, Fritz
Rommer, Paulus
Di Pauli, Franziska
Chan, Andrew
Berger, Thomas
Hegen, Harald
Hoepner, Robert
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2025, 93
[2] Mechanisms of disability progression in primary progressive multiple sclerosis: are they different from secondary progressive multiple sclerosis?
Rudick, R
MULTIPLE SCLEROSIS, 2003, 9 (02): : 210 - 212
[3] Disease activity impacts disability progression in primary progressive multiple sclerosis
Marrodan, M.
Bensi, C.
Pappolla, A.
Rojas, J. I.
Gaitan, M. I.
Ysrraelit, M. C.
Negrotto, L.
Fiol, M. P.
Patrucco, L.
Cristiano, E.
Farez, M. F.
Correale, J.
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 39
[4] Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis
Lunemann, Jan D.
Hegen, Harald
Villar, Luisa Maria
Rejdak, Konrad
Sao-Aviles, Augusto
Carbonell-Mirabent, Pere
Sastre-Garriga, Jaume
Mongay-Ochoa, Neus
Berek, Klaus
Martinez-Yelamos, Sergio
Perez-Miralles, Francisco
Abdelhak, Ahmed
Bachhuber, Franziska
Tumani, Hayrettin
Lycke, Jan N.
Rosenstein, Igal
Alvarez-Lafuente, Roberto
Castillo-Trivino, Tamara
Otaegui, David
Llufriu, Sara
Blanco, Yolanda
Sanchez Lopez, Antonio J.
Garcia Merino, Juan Antonio
Fissolo, Nicolas
Gutierrez, Lucia
Villacieros-Alvarez, Javier
Monreal, Enric
Valls-Carbo, Adrian
Wiendl, Heinz
Montalban, Xavier
Comabella, Manuel
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2024, 11 (04):
[5] Primary progressive multiple sclerosis diagnostic criteria: a reappraisal
Montalban, X.
Sastre-Garriga, J.
Filippi, M.
Khaleeli, Z.
Tellez, N.
Vellinga, M. M.
Tur, C.
Brochet, B.
Barkhof, F.
Rovaris, M.
Miller, D. H.
Polman, C. H.
Rovira, A.
Thompson, A. J.
MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (12) : 1459 - 1465
[6] Disability accumulation in primary progressive multiple sclerosis
Koch, M.
Kingwell, E.
Rieckmann, P.
Tremlett, H.
MULTIPLE SCLEROSIS JOURNAL, 2009, 15 (09) : S40 - S40
[7] Disability Accrual in Primary Progressive & Secondary Progressive Multiple Sclerosis
Harding-Forrester, Sam
Roos, Izanne
Sharmin, Sifat
Diouf, Ibrahima
Malpas, Charles
Nguyen, Ai-Lan
Moradi, Nahid
Horakova, Dana
Havrdova, Eva Kubala
Patti, Francesco
Ayuso, Guillermo Izquierdo
Madueno, Sara Eichau
Prat, Alexandre
Girard, Marc
Duquette, Pierre
Onofrj, Marco
Lugaresi, Alessandra
Grand'Maison, Francois
Weinstock-Guttman, Bianca
Amato, Maria Pia
Grammond, Pierre
Gerlach, Oliver
Ozakbas, Serkan
Sola, Patrizia
Ferraro, Diana
Butzkueven, Helmut
Lechner-Scott, Jeannette
Boz, Cavit
Alroughani, Raed
Van Pesch, Vincent
Cartechini, Elisabetta
Terzi, Murat
Maimone, Davide
Ramo-Tello, Cristina
Spitaleri, Daniele Litterio A.
Kappos, Ludwig
Yamout, Bassem
Sa, Maria Jose
Slee, Mark
Morgado, Yolanda Blanco
Bergamaschi, Roberto
Butler, Ernest
Iuliano, Gerardo
Granella, Franco
Sidhom, Youssef
Gouider, Riadh
Ampapa, Radek
Van Wijmeersch, Bart
Karabudak, Rana
Prevost, Julie
NEUROLOGY, 2021, 96 (15)
[8] Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosis
Fissolo, Nicolas
Benkert, Pascal
Sastre-Garriga, Jaume
Mongay-Ochoa, Neus
Vilaseca-Jolonch, Andreu
Llufriu, Sara
Blanco, Yolanda
Hegen, Harald
Berek, Klaus
Perez-Miralles, Francisco
Rejdak, Konrad
Villar, Luisa M.
Monreal, Enric
Alvarez-Lafuente, Roberto
Soylu, Onder K.
Abdelhak, Ahmed
Bachhuber, Franziska
Tumani, Hayrettin
Martinez-Yelamos, Sergio
Sanchez-Lopez, Antonio J.
Garcia-Merino, Antonio
Gutierrez, Lucia
Castillo-Trivino, Tamara
Lycke, Jan
Rosenstein, Igal
Furlan, Roberto
Filippi, Massimo
Tellez, Nieves
Ramio-Torrenta, Lluis
Lunemann, Jan D.
Wiendl, Heinz
Eichau, Sara
Khalil, Michael
Kuhle, Jens
Montalban, Xavier
Comabella, Manuel
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2024, 95 (05): : 410 - 418
[9] Definitions of primary-progressive multiple sclerosis trajectories by rate of clinical disability progression
Achiron, Anat
Dreyer-Alster, Sapir
Gurevich, Michael
Menascu, Shay
Magalashvili, David
Dolev, Mark
Stern, Yael
Ziv-Baran, Tomer
MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 50
[10] Impact of ocrelizumab on reducing more severe disability progression in primary progressive multiple sclerosis
Kappos, L.
Giovannoni, G.
de Seze, J.
Montalban, X.
Wolinsky, J.
Belachew, S.
Deol-Bhullar, G.
Han, J.
Julian, L.
Hauser, S. L.
EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 44 - 44

← 1 2 3 4 5 →